Crossref
26-A-19849-ACC EVALUATION OF ELECTROPHYSIOLOGIC CHANGES AMONG TRANSGENDER INDIVIDUALS ON GENDER-AFFIRMING HORMONE THERAPY
JACC · 2026-04 · 87 (13) · A117
DOI: 10.1016/j.jacc.2026.02.294 ↗Kurz gefasst
Fachartikel in der Zeitschrift JACC, 2026-04. Verfasst von Marissa Amerongen und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Amerongen, M., Adel, F., Ross, E., Mangold, K., Attia, Z. I., Analuisa, K. Q., Tan, N., & Mankad, R. (2026). 26-A-19849-ACC EVALUATION OF ELECTROPHYSIOLOGIC CHANGES AMONG TRANSGENDER INDIVIDUALS ON GENDER-AFFIRMING HORMONE THERAPY. JACC, 87(13), A117. https://doi.org/10.1016/j.jacc.2026.02.294
Vancouver
Amerongen M, Adel F, Ross E, Mangold K, Attia ZI, Analuisa KQ, et al. 26-A-19849-ACC EVALUATION OF ELECTROPHYSIOLOGIC CHANGES AMONG TRANSGENDER INDIVIDUALS ON GENDER-AFFIRMING HORMONE THERAPY. JACC. 2026;87(13):A117. doi:10.1016/j.jacc.2026.02.294
BibTeX
@article{Amerongen2026,
author = {Amerongen, Marissa and Adel, Fadi and Ross, Emily and Mangold, Kathryn and Attia, Zachi Itzhak and Analuisa, Karol Quelal and Tan, Nicholas and Mankad, Rekha},
title = {26-A-19849-ACC EVALUATION OF ELECTROPHYSIOLOGIC CHANGES AMONG TRANSGENDER INDIVIDUALS ON GENDER-AFFIRMING HORMONE THERAPY},
journal = {JACC},
year = {2026},
volume = {87},
number = {13},
pages = {A117},
doi = {10.1016/j.jacc.2026.02.294}
}
EUVIMED